CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-20 | Polymeropoulos Mihael Hristos President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −73,608 | 79,019 | ||
| 2019-05-17 | Polymeropoulos Mihael Hristos President and CEO | Option exercise | +97,373 | $12.55 | $1.2M | 1,276,343 |
| 2019-05-17 | Polymeropoulos Mihael Hristos President and CEO | Sale | −77,225 | $15.56 | $1.2M | 1,199,118 |
| 2019-05-17 | Polymeropoulos Mihael Hristos President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −97,373 | 152,627 | ||
| 2019-04-23 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2019-03-04 | Reverberi Gian Piero SVP & Chief Commercial Officer | Sale | −443 | $19.92 | $9K | 167,989 |
| 2019-03-04 | Polymeropoulos Mihael Hristos President and CEO | Sale | −38,166 | $19.41 | $741K | 1,178,970 |
| 2019-03-04 | Kelly James Patrick EVP & Chief Financial Officer | Sale | −8,751 | $19.88 | $174K | 209,746 |
| 2019-03-04 | Birznieks Gunther SVP, Business Development | Sale | −8,788 | $19.89 | $175K | 151,251 |
| 2019-03-01 | Reverberi Gian Piero SVP & Chief Commercial Officer | Sale | −438 | $20.17 | $9K | 168,432 |
| 2019-03-01 | Polymeropoulos Mihael Hristos President and CEO | Sale | −6,500 | $20.22 | $131K | 1,217,136 |
| 2019-03-01 | Kelly James Patrick EVP & Chief Financial Officer | Sale | −4,976 | $20.15 | $100K | 218,497 |
| 2019-03-01 | Birznieks Gunther SVP, Business Development | Sale | −3,741 | $20.14 | $75K | 160,039 |
| 2019-02-27 | Williams Timothy SVP & General Counsel | Grant or award | +30,000 | 60,000 | ||
| 2019-02-27 | Williams Timothy SVP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2019-02-27 | Reverberi Gian Piero SVP & Chief Commercial Officer | Grant or award | +30,000 | 168,870 | ||
| 2019-02-27 | Reverberi Gian Piero SVP & Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2019-02-27 | Polymeropoulos Mihael Hristos President and CEO | Grant or award | +60,000 | 1,223,636 | ||
| 2019-02-27 | Polymeropoulos Mihael Hristos President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2019-02-27 | Kelly James Patrick EVP & Chief Financial Officer | Grant or award | +30,000 | 223,473 |
Page 17 of 20 · 387 trades